INGN Q3 2024 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$89M+5.8% YoY

Gross Profit

$41M46.5% margin

Operating Income

-$8M-8.8% margin

Net Income

-$6M-6.7% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$306M

Total Liabilities

$121M

Stockholders' Equity

$185M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$84M	+5.8%
Gross Profit	$41M	$34M	+22.4%
Operating Income	-$8M	-$47M	+83.3%
Net Income	-$6M	-$46M	+87.0%

Geographic Segments

UNITED STATES

$57M64%

Non-US

$32M36%